AIM - International Association of Mutual Benefit Societies

The International Association of Mutual Benefit Societies (AIM), representing not-for-profit health insurance funds and health mutuals in Europe, Africa and Middle East as well as Latin America, regard the newly Commission proposal on simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, COM(2025) 1023, as a step in the right direction.

AIM welcomes the release of the European Commission’s inception impact assessment on the revision of the basic pharmaceutical legislation. AIM, the International Association of Mutual Benefit Societies, is providing its preliminary feedback on the roadmap. AIM calls for the following actions: To improve medicines’ affordability o Create an expert group on medicines cost transparency.

The International Association of Mutual Benefit Societies (AIM) is an international umbrella organisation of federations of health mutuals and other not-for-profit healthcare payers, which provide compulsory/and/or supplementary health coverage to around 230 million people around the world, including close to 200 million people in Europe, on a not-for-profit basis.

The health insurance funds and not-for-profit health insurers of AIM agree with the huge potential that a flexible use of health data has for patient centeredness as well as improving healthcare quality and outcome.

AIM, the International Association of Mutual Benefit Societies, the leading international association of not-for-profit healthcare insurers, representing not-for- profit organisations providing health coverage to around 200 million people in Europe, welcomes the European Commission’s proposal to revise the framework for standards of quality and safety for substances of human origin.

AIM welcomes the steps taken by the European Commission to revise the orphan medicinal products legislation, taking stock of 20 years of operation. While the current legislative framework has brought a number of useful medicinal products to the market, now is a good time to reflect what has worked and not worked in terms of the regulatory framework reaching its objectives.

AIM, the International Association of Mutual Benefit Societies (AIM,) is an international umbrella organisation of federations of health mutuals and health insurance bodies counting with 52 members from 28 countries around Europe, Latin America and Africa and the Middle East.

AIM is the international umbrella organisation of federations of health mutuals and other not-for-profit healthcare payers. Its 54 members from 28 countries in Europe, Latin America and Africa and the Middle East provide compulsory and/or supplementary health coverage to around 240 million people around the world, including close to 200 million people in Europe, on a not-for-profit basis.

AIM is the international umbrella organisation of federations of health mutuals and other not-for-profit healthcare payers. Its 54 members from 28 countries in Europe, Latin America and Africa and the Middle East provide compulsory and/or supplementary health coverage to around 240 million people around the world, including close to 200 million people in Europe, on a not-for-profit basis.

AIM welcomes the opportunity to provide feedback on the on the evaluation of excise duty rates and tax structures. Increased Taxation as a best buy for Public Health Increasing the price of alcohol is one of the most cost-effective alcohol policies available. Pricing policies have also been identified by WHO as second “best buy” in the fight against non-communicable diseases.